APA (7th ed.) Citation

Kishk, A., Pacheco, M. P., Heurtaux, T., & Sauter, T. (2024). Metabolic models predict fotemustine and the combination of eflornithine/rifamycin and adapalene/cannabidiol for the treatment of gliomas. Briefings in Bioinformatics, 25(3), 1. https://doi.org/10.1093/bib/bbae199

Chicago Style (17th ed.) Citation

Kishk, Ali, Maria Pires Pacheco, Tony Heurtaux, and Thomas Sauter. "Metabolic Models Predict Fotemustine and the Combination of Eflornithine/rifamycin and Adapalene/cannabidiol for the Treatment of Gliomas." Briefings in Bioinformatics 25, no. 3 (2024): 1. https://doi.org/10.1093/bib/bbae199.

MLA (9th ed.) Citation

Kishk, Ali, et al. "Metabolic Models Predict Fotemustine and the Combination of Eflornithine/rifamycin and Adapalene/cannabidiol for the Treatment of Gliomas." Briefings in Bioinformatics, vol. 25, no. 3, 2024, p. 1, https://doi.org/10.1093/bib/bbae199.